Concepedia

Ru Feng

RF

44

Publications

1.7K

Citations

23

H-Index

2010

Active since

Affiliations

Nanfang Hospital(Current)

Southern Medical University

Peking University

Chinese Academy of Medical Sciences & Peking Union Medical College

Henan Cancer Hospital

Ru Feng is an author at Nanfang Hospital specializing in medicine, immunology, and hematology.

ORCID

Top concepts

Publications per year

2010–2025

44

Publications

44

Liproxstatin-1 attenuates unilateral ureteral obstruction-induced renal fibrosis by inhibiting renal tubular epithelial cells ferroptosis

Bo Zhang, Xiang Chen, Ru Feng et al. · Cell Death and Disease · 2021 · 201 citations · Full text

Treatment of Patients with Relapsed or Refractory Mantle–Cell Lymphoma with Zanubrutinib, a Selective Inhibitor of Bruton's Tyrosine Kinase

Yuqin Song, Keshu Zhou, Dehui Zou et al. · Clinical Cancer Research · 2020 · 176 citations

Zanubrutinib in relapsed/refractory mantle cell lymphoma: long-term efficacy and safety results from a phase 2 study

Yuqin Song, Keshu Zhou, Dehui Zou et al. · Blood · 2022 · 143 citations · Full text

, , +17

Treatment of relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma with the BTK inhibitor zanubrutinib: phase 2, single-arm, multicenter study

Wei Xu, Shenmiao Yang, Keshu Zhou et al. · Journal of Hematology & Oncology · 2020 · 128 citations · Full text

HOXBLINC long non-coding RNA activation promotes leukemogenesis in NPM1-mutant acute myeloid leukemia

Ganqian Zhu, Huacheng Luo, Yang Feng et al. · Nature Communications · 2021 · 93 citations · Full text

Rows per page

1–5 of 44